You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 2, February 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Complementary and Alternative Medicine
 •Depression
 •Psychotherapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression

Peter J. Schmidt, MD; Robert C. Daly, MD; Miki Bloch, MD; Mark J. Smith, MD, PhD; Merry A. Danaceau, RN; Linda Simpson St. Clair, RN; Jean H. Murphy, RN, MSN; Nazli Haq, MA; David R. Rubinow, MD

Arch Gen Psychiatry. 2005;62:154-162.

Context  Alternative and over-the-counter medicines have become increasingly popular choices for many patients who prefer not to take traditional antidepressants. The adrenal androgen and neurosteroid dehydroepiandrosterone (DHEA) is available as over-the-counter hormonal therapy and previously has been reported to have antidepressant-like effects.

Objective  To evaluate the efficacy of DHEA as a monotherapy treatment for midlife-onset depression.

Design  A double-blind, randomized, placebo-controlled, crossover treatment study was performed from January 4, 1996, through August 31, 2002.

Settings  The National Institute of Mental Health Midlife Outpatient Clinic in the National Institutes of Health Clinical Center, Bethesda, Md.

Patients  Men (n = 23) and women (n = 23) aged 45 to 65 years with midlife-onset major or minor depression participated in this study. None of the subjects received concurrent antidepressant medications.

Intervention  Six weeks of DHEA therapy, 90 mg/d for 3 weeks and 450 mg/d for 3 weeks, and 6 weeks of placebo.

Main Outcome Measures  The 17-Item Hamilton Depression Rating Scale and Center for Epidemiologic Studies Depression Scale. Additional measures included the Derogatis Interview for Sexual Functioning. Results were analyzed by means of repeated-measures analysis of variance and post hoc Bonferroni t tests.

Results  Six weeks of DHEA administration was associated with a significant improvement in the 17-Item Hamilton Depression Rating Scale and the Center for Epidemiologic Studies Depression Scale ratings compared with both baseline (P<.01) and 6 weeks of placebo treatment (P<.01). A 50% or greater reduction in baseline Hamilton Depression Rating Scale scores was observed in 23 subjects after DHEA and in 13 subjects after placebo treatments. Six weeks of DHEA treatment also was associated with significant improvements in Derogatis Interview for Sexual Functioning scores relative to baseline and placebo conditions.

Conclusion  We find DHEA to be an effective treatment for midlife-onset major and minor depression.


Author Affiliations: Behavioral Endocrinology Branch, National Institute of Mental Health, Rockville, Md (Drs Schmidt, Daly, Bloch, Smith, and Rubinow, and Mss Simpson St Clair, Murphy, and Haq); and Clinical Center Nursing Department, National Institutes of Health, Department of Health and Human Services, Bethesda, Md (Ms Danaceau).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Targeting the HPA axis in major depression: does it work?: INVITED COMMENTARY ON... ANTIGLUCOCORTICOIDS IN PSYCHIATRY
Claes
Adv. Psychiatr. Treat. 2009;15:250-252.
ABSTRACT | FULL TEXT  

Dehydroepiandrosterone and Corticosterone Are Regulated by Season and Acute Stress in a Wild Songbird: Jugular Versus Brachial Plasma
Newman et al.
Endocrinology 2008;149:2537-2545.
ABSTRACT | FULL TEXT  

Major Depressive Disorder
Belmaker and Agam
NEJM 2008;358:55-68.
FULL TEXT  

DHEA therapy for women: effect on sexual function and wellbeing
Panjari and Davis
Hum Reprod Update 2007;13:239-248.
ABSTRACT | FULL TEXT  

Augmentation and combination strategies for depression
DeBattista
J Psychopharmacol 2006;20:11-18.
ABSTRACT  

Androgen therapy in women
Arlt
Eur J Endocrinol 2006;154:1-11.
ABSTRACT | FULL TEXT  

Is DHEA an Effective Antidepressant?
JWatch Psychiatry 2005;2005:10-10.
FULL TEXT  

Is DHEA an Effective Antidepressant?
JWatch Women's Health 2005;2005:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.